Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats.

Por Popoli, P., Pezzola, A., Sagratella, S., Zeng, Y. C., Scotti de Carolis, A.
Publicado em 1991

Comparative efficacy of whole-brain radiotherapy with and without elemene liposomes in patients with multiple brain metastases from non-small-cell lung carcinoma

Por Sun, Y.N., Zhang, Z.Y., Zeng, Y.C., Chi, F., Jin, X.Y., Wu, R.
Publicado no Curr Oncol (2016)

Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage

Por Li, G, Fan, R-M, Chen, J-L, Wang, C-M, Zeng, Y-C, Han, C, Jiao, S, Xia, X-P, Chen, W, Yao, S-T
Publicado em 2014

Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

Por Zeng, Y.C., Wu, R., Xiao, Y.P., Chi, F., Xue, M., Zhang, Z.Y., Xing, R., Zhong, W.Z., Wang, S.L., Tian, X., Chen, W., Chen, J.J., Wu, L.N.
Publicado no Curr Oncol (2015)